| 144060-53-7 Basic information More.. |
Product Name: | Febuxostat | Synonyms: | Febuxostat (Uloric);Febuxostat (TEI-6720);Febuxostat Tablets;FEBUXOSTAT API;Febuxostat (This product is unavailable in the U.S.);Febuxostat Tabletshehe;Febuxostat
2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid;Febuxostat, >=99% | CAS: | 144060-53-7 | MF: | C16H16N2O3S | MW: | 316.37 | EINECS: | 682-158-6 | Mol File: | 144060-53-7.mol | |
Use
Febuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues.
- Febuxostat
-
- US $0.00 / Kg/Bag
- 2024-11-07
- CAS:144060-53-7
- Min. Order: 2Kg/Bag
- Purity: 99% up, High Density
- Supply Ability: 20 tons
- Febuxostat
-
- US $0.00 / kg
- 2024-11-07
- CAS:144060-53-7
- Min. Order: 1kg
- Purity: 99%min
- Supply Ability: 20ton
- Febuxostat
-
- US $6.00-5.00 / kg
- 2024-11-07
- CAS:144060-53-7
- Min. Order: 1kg
- Purity: 95%
- Supply Ability: 1000kg
|
144060-53-7
Recommend Suppliers |
|